{
  "trial_id": "NCT00869050",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "metastatic neuroendocrine tumor",
      "label": "met",
      "evidence": "MRI"
    },
    {
      "criterion": "progressive metastatic disease",
      "label": "met",
      "evidence": "CT scan"
    },
    {
      "criterion": "carcinoid tumors",
      "label": "met",
      "evidence": "patient text"
    },
    {
      "criterion": "pancreatic neuroendocrine tumors",
      "label": "met",
      "evidence": "patient text"
    },
    {
      "criterion": "pheochromocytomas",
      "label": "met",
      "evidence": "patient text"
    },
    {
      "criterion": "neuroendocrine tumors of unknown primary site",
      "label": "met",
      "evidence": "patient text"
    },
    {
      "criterion": "measurable disease",
      "label": "met",
      "evidence": "CT scan"
    },
    {
      "criterion": "non pregnant females",
      "label": "met",
      "evidence": "patient text"
    },
    {
      "criterion": "men and women of childbearing potential",
      "label": "met",
      "evidence": "patient text"
    }
  ],
  "exclusion": [
    {
      "criterion": "prior chemotherapy with capecitabine or temozolomide",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "hypersensitivity to capecitabine, 5-FU, temozolomide or DTIC",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "serious medical or psychiatric illness preventing informed consent",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "tumor spread to central brain and spinal cord",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "HIV-positive patients",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "prior malignancies in the last 5 years",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "notes": "Patient has a history of anaplastic astrocytoma, but does not meet inclusion criteria for metastatic neuroendocrine tumor. Patient is also on high-dose steroids and has hypertension.",
  "_meta": {
    "topic_id": "1",
    "trial_id": "NCT00869050",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_test10_top50"
  }
}